Let me ask the following question to the board:
Why is this the header of the press release (in blue and bold letters
Why are we in in discussions with MHRA and Health Canada after unblinding
(while simultaneously talking to FDA) ???
Where I stand this is far
from a "nothing burger" as some are trying to suggest. If the data was not good, would we be "talking" to them ???